ArticleBlood advances2019

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Nicola Gökbuget et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.